We deliver GMP-compliant, process-customized mixing tank systems specifically engineered for sensitive mRNA-LNP vaccine formulation and biologic nanoparticle preparation. Tailored to address the unique instability of naked mRNA and shear-sensitive lipid nanoparticles, our specialized mixing tanks support homogeneous buffer compounding, aqueous-lipid phase blending, stable intermediate holding and final formulation homogenization. Optimized for full-process RNase-free control and low-disturbance fluid performance, the systems maintain intact mRNA integrity and consistent LNP particle size distribution, delivering reliable, audit-ready formulation infrastructure for clinical trial and commercial mRNA vaccine manufacturing.
Our customized tank design follows core philosophies of RNase-free sanitary guarantee, low-shear gentle mixing, precise thermal stabilization and zero-dead-volume fluid management. Constructed with ultra-clean 316L stainless steel and low-adsorption polished surfaces, all wetted components eliminate nucleic acid adhesion and exogenous contamination. Customized low-turbulence agitation geometry avoids LNP structural damage and particle aggregation during blending. Integrated jacketed temperature control and sealed closed-loop structure stabilize formulation microenvironments, while full CIP/SIP compatibility ensures repeatable, validated sanitization for multi-batch GMP production.
All structural design, material certification and operational specifications fully comply with FDA mRNA manufacturing guidance, EMA Annex 1, ICH Q-series and ISPE biologic manufacturing standards. The intelligent control system meets 21 CFR Part 11 data integrity requirements, capturing full real-time data of mixing speed, temperature, holding duration and batch parameters with immutable audit trails. With verified RNase-free status, ultra-low extractables and leachables, and stable bioburden control, the systems sustain continuous inspection readiness for global vaccine registration and regulatory audits.
We provide end-to-end tailored solutions including formulation process docking, personalized tank configuration, structural optimization, on-site installation, system commissioning and complete IQ/OQ/PQ qualification deliverables. Our specialized mRNA-LNP mixing tank systems eliminate formulation batch deviation, reduce nanoparticle heterogeneity and maximize active product retention rate. Clients obtain stable, compliant and process-adaptive formulation equipment to ensure consistent vaccine quality, accelerate production cycles and strengthen competitiveness in the global nucleic acid vaccine market.
